Veli-Matti Kähäri Selected Research

Radiotherapy

3/2006

Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Veli-Matti Kähäri Research Topics

Disease

45	Neoplasms (Cancer) 01/2022 - 01/2002
22	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2002
14	Neoplasm Metastasis (Metastasis) 11/2021 - 02/2002
11	Melanoma (Melanoma, Malignant) 02/2021 - 02/2002
5	Inflammation (Inflammations) 01/2021 - 01/2013
5	Skin Neoplasms (Skin Cancer) 11/2018 - 03/2003
4	Actinic Keratosis 09/2020 - 02/2015
4	Carcinogenesis 01/2017 - 06/2002
4	Wounds and Injuries (Trauma) 10/2015 - 03/2003
3	Carcinoma (Carcinomatosis) 01/2021 - 08/2010
3	Fibrosis (Cirrhosis) 01/2013 - 05/2008
3	Salivary Gland Neoplasms (Salivary Gland Cancer) 08/2010 - 04/2008
2	Basal Cell Carcinoma (Rodent Ulcer) 09/2020 - 06/2009
2	Seborrheic Keratosis 01/2020 - 02/2015
2	Papilloma (Papillomatosis) 05/2017 - 02/2015
2	Hypoxia (Hypoxemia) 07/2010 - 02/2010
2	Squamous Cell Carcinoma of Head and Neck 04/2010 - 03/2006
2	Head and Neck Neoplasms (Head and Neck Cancer) 03/2006 - 03/2003
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Bowen's Disease (Disease, Bowen) 01/2017
1	Myoma 01/2017
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 02/2015
1	Breast Neoplasms (Breast Cancer) 02/2013
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2011
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2011
1	Experimental Liver Cirrhosis 01/2011
1	Infections 10/2010
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2009
1	Skin Ulcer 01/2007

Drug/Important Bio-Agent (IBA)

18	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2002
10	Matrix Metalloproteinase 13IBA 01/2022 - 01/2002
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2011
7	Messenger RNA (mRNA)IBA 01/2022 - 10/2002
6	Proteins (Proteins, Gene)FDA Link 09/2021 - 01/2003
5	CollagenIBA 01/2022 - 01/2007
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 09/2008
5	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 03/2003
4	Biological ProductsIBA 02/2021 - 02/2002
4	IntegrinsIBA 11/2018 - 10/2004
4	Tissue Inhibitor of Metalloproteinase-3IBA 01/2013 - 06/2002
4	Transforming Growth Factor beta (TGF-beta)IBA 07/2010 - 11/2007
3	chemotactic factor inactivatorIBA 11/2021 - 02/2015
3	Complement Factor I (C3b Inactivator)IBA 11/2021 - 02/2015
3	Metalloproteases (Metalloproteinases)IBA 11/2021 - 09/2008
3	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 07/2007
3	Complementary DNA (cDNA)IBA 01/2021 - 01/2002
3	RNA (Ribonucleic Acid)IBA 01/2020 - 12/2005
3	Long Noncoding RNAIBA 01/2020 - 01/2016
3	Complement System Proteins (Complement)IBA 07/2019 - 01/2016
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 01/2020
2	Laminin (Merosin)IBA 01/2017 - 01/2016
2	Complement Factor H (Factor H)IBA 01/2016 - 02/2014
2	CytokinesIBA 08/2014 - 09/2008
2	ChemokinesIBA 08/2014 - 09/2008
2	Small Interfering RNA (siRNA)IBA 03/2014 - 07/2010
2	Death Domain ReceptorsIBA 02/2011 - 04/2003
2	Caspase 8 (Caspase-8)IBA 02/2011 - 04/2003
2	Caspase 3 (Caspase-3)IBA 10/2010 - 04/2003
2	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 08/2010 - 07/2005
2	Tissue Inhibitor of MetalloproteinasesIBA 04/2010 - 06/2002
2	Collagenases (Collagenase)FDA Link 11/2009 - 03/2005
2	collagenase 1IBA 07/2005 - 02/2002
2	Matrix Metalloproteinase InhibitorsIBA 05/2005 - 05/2002
2	matrix metalloproteinase 19IBA 11/2003 - 03/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2003 - 10/2002
1	Complement Factor D (Factor D)IBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2020
1	Isosorbide FDA Link 09/2020
1	NitratesIBA 09/2020
1	InflammasomesIBA 07/2017
1	Complement Factor B (Factor B)IBA 05/2017
1	Dasatinib (BMS 354825)FDA Link 01/2017
1	Collagen Type XVIIIBA 01/2017
1	KalininIBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 12/2016
1	Collagen Type XVIII (Type XVIII Collagen)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2014
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012
1	Fibroblast Growth Factor 7 FDA Link 01/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 09/2011
1	SerpinsIBA 09/2011
1	SuspensionsIBA 02/2011
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2011
1	Factor X (Stuart Factor)IBA 10/2010
1	Annexin A5IBA 10/2010
1	Antineoplastic Agents (Antineoplastics)IBA 10/2010
1	Urocanic AcidIBA 10/2010
1	DisintegrinsIBA 04/2010
1	ThrombospondinsIBA 04/2010
1	Peptides (Polypeptides)IBA 11/2007
1	Vascular Endothelial Growth Factor CIBA 01/2007

Therapy/Procedure

6	Therapeutics 01/2021 - 06/2002
3	Drug Therapy (Chemotherapy) 01/2014 - 05/2005
1	Radiotherapy 03/2006